This provider's $4.7M in total Medicare payments ranks in the 96th percentile of Hematology-Oncology providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $283.69 | $96.59 | 2.94x | $187.10 | $691.0K | 12.2K | 2.9K |
| 2015 | $335.93 | $119.80 | 2.80x | $216.13 | $554.3K | 9.4K | 2.6K |
| 2016 | $294.94 | $108.24 | 2.72x | $186.70 | $568.3K | 11.0K | 3.1K |
| 2017 | $311.95 | $113.33 | 2.75x | $198.62 | $484.0K | 11.4K | 3.2K |
| 2018 | $344.66 | $126.80 | 2.72x | $217.86 | $586.6K | 12.7K | 3.4K |
| 2019 | $148.05 | $35.07 | 4.22x | $112.98 | $377.1K | 12.6K | 3.4K |
| 2020 | $161.88 | $40.76 | 3.97x | $121.12 | $297.4K | 10.0K | 2.9K |
| 2021 | $166.16 | $42.94 | 3.87x | $123.22 | $350.4K | 10.4K | 3.1K |
| 2022 | $184.20 | $46.06 | 4.00x | $138.14 | $385.5K | 11.3K | 3.4K |
| 2023 | $171.78 | $40.43 | 4.25x | $131.35 | $374.3K | 11.4K | 3.1K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim, 6 mg | 360 | $1.1M | $3.0K | 2.03x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 11.1K | $1.0M | $93.32 | 2.42x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 4.1K | $522.5K | $127.75 | 5.40x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 5.5K | $353.4K | $63.81 | 2.70x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 2.3K | $159.6K | $69.96 | 4.00x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 16.4K | $147.8K | $9.02 | 6.75x |
| J3490 | Unclassified drugs | 2.0K | $140.6K | $70.36 | 4.57x |
| 80053 | Blood test, comprehensive group of blood chemicals | 12.3K | $139.9K | $11.41 | 10.23x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 1.0K | $138.4K | $135.40 | 2.70x |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | 2.0K | $123.5K | $61.82 | 3.26x |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | 776 | $111.6K | $143.83 | 2.46x |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 4.0K | $68.8K | $17.18 | 7.87x |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 3.8K | $65.9K | $17.31 | 4.92x |
| 36415 | Insertion of needle into vein for collection of blood sample | 16.9K | $59.0K | $3.49 | 9.20x |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | 432 | $50.8K | $117.55 | 3.55x |
| J9310 | Injection, rituximab, 100 mg | 54 | $38.4K | $710.30 | 1.83x |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | 624 | $37.6K | $60.18 | 5.44x |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | 358 | $32.7K | $91.47 | 3.14x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 161 | $29.3K | $181.70 | 2.55x |
| 82728 | Ferritin (blood protein) level | 1.9K | $28.1K | $14.87 | 5.19x |
This provider submits charges 3.71 times higher than what Medicare actually pays.
A markup ratio of 3.71x means for every $100 Medicare pays, this provider initially charges $371. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Bhavesh Balar, MD | Freehold, NJ | $36.9M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data